p53 and p16Ink4a/p19ArfLoss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells.
In human studies and mouse models, the contributions of p53 and p16Ink4a/p19Arfloss are well established in pancreatic ductal adenocarcinoma (PDAC). Although loss of functional p53 pathway and loss of Ink4a/Arf in human pancreatic acinar cell carcinoma (PACC) and pancreatic neuroendocrine tumor (PanNET) are identified, their direct roles in tumorigenesis of PACC and PanNET remain to be determined. Using transgenic mouse models expressing the viral oncogene polyoma middle T antigen (PyMT), we demonstrate that p53 loss in pancreatic Pdx1+ progenitor cells results in aggressive PACC, whereas Ink4a/Arf loss results in PanNETs. Concurrent loss of p53 and Ink4a/Arf resembles loss of p53 alone, suggesting that Ink4a/Arf loss has no additive effect to PACC progression. Our results show that specific tumor suppressor genotypes provocatively influence the tumor biological phenotypes in pancreatic progenitor cells. Additionally, in a mouse model of β-cell hyperplasia, we demonstrate that p53 and Ink4a/Arf play cooperative roles in constraining the progression of PanNETs.
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Stephanie
S
Azzopardi
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Sharon
S
Pang
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
David S
DS
Klimstra
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: nad2012@med.cornell.edu.
Yi-Chieh Nancy
YN
Du
D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000172:deficiency*; D050764:Cyclin-Dependent Kinase Inhibitor p19 / Q000172:deficiency*; D004195:Disease Models, Animal; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D053208:Kaplan-Meier Estimate; D051379:Mice; D008822:Mice, Transgenic; D009362:Neoplasm Metastasis; D014411:Neoplastic Stem Cells / Q000378:metabolism*; D018358:Neuroendocrine Tumors / Q000235:genetics / Q000401:mortality / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology*; D010641:Phenotype; D011379:Prognosis; D047368:Tumor Burden; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency*
D019941:Cyclin-Dependent Kinase Inhibitor p16; D050764:Cyclin-Dependent Kinase Inhibitor p19; D016159:Tumor Suppressor Protein p53
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12236-41
12221286
Cancer Discov. 2014 Dec;4(12):1398-405
25266736
J Pathol. 2014 Mar;232(4):428-35
24293293
Cancer Res. 2003 Mar 1;63(5):1046-53
12615721
Nat Genet. 2001 Dec;29(4):418-25
11694875
Development. 1996 Mar;122(3):983-95
8631275
Nat Rev Cancer. 2002 Dec;2(12):951-6
12459733
Mol Cell. 2003 Nov;12 (5):1151-64
14636574
Virchows Arch. 2016 Mar;468(3):289-96
26586531
Virchows Arch. 2014 Dec;465(6):661-72
25298229
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5947-52
16585505
Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):1128-32
1371010
J Clin Invest. 1994 Dec;94(6):2421-5
7989599
J Surg Oncol. 2013 Jan;107(1):67-77
22711682
Nature. 2001 Sep 6;413(6851):83-6
11544530
Neuroendocrinology. 2013;97(1):67-73
22441103
Cancer Cytopathol. 2013 Aug;121(8):459-70
23408736
Nat Genet. 2002 Sep;32(1):128-34
12185368
Science. 2011 Mar 4;331(6021):1199-203
21252315
Oncogene. 2003 Mar 27;22(12):1822-35
12660818
Cancer Cell. 2002 May;1(4):339-53
12086849
Oncogene. 2015 Aug 6;34(32):4190-8
25362852
J Pathol Transl Med. 2015 Jan;49(1):13-22
25812653
Ann Surg. 2003 Sep;238(3):423-31; discussion 431-2
14501508
Oncol Lett. 2013 Dec;6(6):1641-1645
24260058
Cancer Res. 1998 Jan 15;58(2):237-40
9443399
Front Med (Lausanne). 2015 Jun 15;2:41
26137463
Br J Cancer. 2001 Jan;84(2):253-62
11161385
Cancer Res. 1994 Mar 15;54(6):1556-60
8137263
Ann N Y Acad Sci. 2004 Apr;1014:284-99
15153447
Mol Cell. 2003 Feb;11(2):415-24
12620229
Am J Pathol. 2008 Apr;172(4):1081-7
18310506
Int J Cancer. 2012 Sep 1;131(5):1013-22
22437917
PLoS One. 2009 Sep 07;4(9):e6932
19812721
Cancer Cell. 2005 May;7(5):469-83
15894267
PLoS One. 2010 Aug 27;5(8):e12454
20805995
Genes Cancer. 2010 May 15;1(4):360-368
20871795
Am J Surg Pathol. 2012 Dec;36(12):1782-95
23026929
Virchows Arch. 2014 May;464(5):553-64
24590585
Nature. 1983 Jun 2-8;303(5916):435-9
6304524
Cell. 1998 Mar 20;92 (6):713-23
9529248
Int J Cancer. 2000 Dec 1;88(5):772-7
11072247
Genes Dev. 2003 Dec 15;17(24):3127-38
14681205
Cell. 1998 Mar 20;92 (6):725-34
9529249
Mol Cancer Res. 2011 Jul;9(7):867-77
21636682